Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Genix Pharmaceuticals Corporation
  6. Summary
    GENX   CA37232A1093

GENIX PHARMACEUTICALS CORPORATION

(GENX)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Bourse De Toronto
01/06/2022 01/10/2022 01/11/2022 01/13/2022 01/14/2022 Date
0.11(c) 0.12(c) 0.115(c) 0.12(c) 0.11(c) Last
8 000 53 000 8 000 8 000 483 000 Volume
+9.09% -4.17% +4.35% -8.33% Change
More quotes
Estimated financial data (e)
Sales 2019 0,14 M 0,11 M 0,11 M
Net income 2019 -0,16 M -0,13 M -0,13 M
Net cash position 2019 0,01 M 0,01 M 0,01 M
P/E ratio 2019 -15,9x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -0,72 M -0,57 M -0,57 M
Net cash position 2020 0,68 M 0,54 M 0,54 M
P/E ratio 2020 -11,5x
Yield 2020 -
Capitalization 6,51 M 5,19 M 5,19 M
EV / Sales 2019 19,0x
EV / Sales 2020 -
Nbr of Employees -
Free-Float 55,5%
More Financials
Company
Genix Pharmaceuticals Corporation is a Canada-based life-sciences company that is focused on the research, development, manufacturing, sales and distribution of branded and generic ophthalmic drugs and ophthalmic over-the-counter products. The Company holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X... 
Sector
Food Processing
Calendar
03/01Earnings Release
More about the company
All news about GENIX PHARMACEUTICALS CORPORATION
2021Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter Ended ..
CI
2021GENIX PHARMACEUTICALS CORP : oration Receives Natural Product Number for Rechlor from Heal..
AQ
2021Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License
NE
2021Genix Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter Ended..
CI
2021GENIX PHARMACEUTICALS : Starts Trading on OTCQB Venture Market Exchange
MT
2021Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange
NE
2021Genix Pharmaceuticals Corporation Provides a Corporate Update to Shareholders
NE
2021Genix Pharmaceuticals Corporation Appoints Mahmoud Aziz to the Board and as President
CI
2021Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement fo..
CI
2021Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement fo..
NE
2021Genix Pharmaceuticals Corporation Prepares to File Abbreviated New Drug Submissions for..
CI
2021Genix Pharmaceuticals Corporation Prepares to File Abbreviated New Drug Submissions (AN..
NE
2021Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended Octo..
CI
2020Genix Pharmaceuticals Corporation Announces Executive Changes
CI
2020Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter Ended ..
CI
More news
News in other languages on GENIX PHARMACEUTICALS CORPORATION

- No features available -

More news
Chart GENIX PHARMACEUTICALS CORPORATION
Duration : Period :
Genix Pharmaceuticals Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Sina Salehi Pirooz Chief Executive Officer & Director
Mahmoud S. Aziz President & Director
Danny W. K. Lee Chief Financial Officer
Kevin James Bottomley Independent Director
Paul Chow Independent Director
Sector and Competitors